1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Europe Transdermal Medical Patch Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Europe Transdermal Medical Patch Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Europe Transdermal Medical Patch Market Regional Analysis
6.2 Europe Transdermal Medical Patch Market Revenue 2021-2028 (US$ Million)
6.3 Europe Transdermal Medical Patch Market Forecast Analysis
7. Europe Transdermal Medical Patch Market Analysis – by Type
7.1 Single Layer Drug-in-Adhesive
- 7.1.1 Overview
- 7.1.2 Single Layer Drug-in-Adhesive: Europe Transdermal Medical Patch Market – Revenue and Forecast, 2021-2028 (US$ Million)
7.2 Multi-layer Drug-in-Adhesive
- 7.2.1 Overview
- 7.2.2 Multi-layer Drug-in-Adhesive: Europe Transdermal Medical Patch Market – Revenue and Forecast, 2021-2028 (US$ Million)
7.3 Reservoir
- 7.3.1 Overview
- 7.3.2 Reservoir: Europe Transdermal Medical Patch Market – Revenue and Forecast, 2021-2028 (US$ Million)
7.4 Vapor Patch
- 7.4.1 Overview
- 7.4.2 Vapor Patch: Europe Transdermal Medical Patch Market – Revenue and Forecast, 2021-2028 (US$ Million)
7.5 Matrix
- 7.5.1 Overview
- 7.5.2 Matrix: Europe Transdermal Medical Patch Market – Revenue and Forecast, 2021-2028 (US$ Million)
8. Europe Transdermal Medical Patch Market Analysis – by Application
8.1 Neurologic Conditions
- 8.1.1 Overview
- 8.1.2 Neurologic Conditions: Europe Transdermal Medical Patch Market – Revenue and Forecast, 2021-2028 (US$ Million)
8.2 Pain Management
- 8.2.1 Overview
- 8.2.2 Pain Management: Europe Transdermal Medical Patch Market – Revenue and Forecast, 2021-2028 (US$ Million)
8.3 Nicotine Cessation
- 8.3.1 Overview
- 8.3.2 Nicotine Cessation: Europe Transdermal Medical Patch Market – Revenue and Forecast, 2021-2028 (US$ Million)
8.4 Cardiovascular Disorders
- 8.4.1 Overview
- 8.4.2 Cardiovascular Disorders: Europe Transdermal Medical Patch Market – Revenue and Forecast, 2021-2028 (US$ Million)
8.5 Hormonal Therapy
- 8.5.1 Overview
- 8.5.2 Hormonal Therapy: Europe Transdermal Medical Patch Market – Revenue and Forecast, 2021-2028 (US$ Million)
9. Europe Transdermal Medical Patch Market Analysis – by Distribution Channel
9.1 Hospital Pharmacies
- 9.1.1 Overview
- 9.1.2 Hospital Pharmacies: Europe Transdermal Medical Patch Market – Revenue and Forecast, 2021-2028 (US$ Million)
9.2 Retail Pharmacies
- 9.2.1 Overview
- 9.2.2 Retail Pharmacies: Europe Transdermal Medical Patch Market – Revenue and Forecast, 2021-2028 (US$ Million)
9.3 Online Pharmacies
- 9.3.1 Overview
- 9.3.2 Online Pharmacies : Europe Transdermal Medical Patch Market – Revenue and Forecast, 2021-2028 (US$ Million)
10. Europe Transdermal Medical Patch Market – Europe Analysis
10.1 Overview
10.2 Europe
- 10.2.1 Europe Transdermal Medical Patch Market Breakdown, by Key
Country, 2024 and 2028 (%)
- 10.2.1.1 Europe Transdermal Medical Patch Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 UK:
Europe Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.1.1 UK: Europe Transdermal Medical Patch Market Breakdown, by Type
- 10.2.1.1.2 UK: Europe Transdermal Medical Patch Market Breakdown, by Application
- 10.2.1.1.3 UK: Europe Transdermal Medical Patch Market Breakdown, by Distribution Channel
- 10.2.1.2 Germany:
Europe Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.2.1 Germany: Europe Transdermal Medical Patch Market Breakdown, by Type
- 10.2.1.2.2 Germany: Europe Transdermal Medical Patch Market Breakdown, by Application
- 10.2.1.2.3 Germany: Europe Transdermal Medical Patch Market Breakdown, by Distribution Channel
- 10.2.1.3 France:
Europe Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.3.1 France: Europe Transdermal Medical Patch Market Breakdown, by Type
- 10.2.1.3.2 France: Europe Transdermal Medical Patch Market Breakdown, by Application
- 10.2.1.3.3 France: Europe Transdermal Medical Patch Market Breakdown, by Distribution Channel
- 10.2.1.4 Russia:
Europe Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.4.1 Russia: Europe Transdermal Medical Patch Market Breakdown, by Type
- 10.2.1.4.2 Russia: Europe Transdermal Medical Patch Market Breakdown, by Application
- 10.2.1.4.3 Russia: Europe Transdermal Medical Patch Market Breakdown, by Distribution Channel
- 10.2.1.5 Italy:
Europe Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.5.1 Italy: Europe Transdermal Medical Patch Market Breakdown, by Type
- 10.2.1.5.2 Italy: Europe Transdermal Medical Patch Market Breakdown, by Application
- 10.2.1.5.3 Italy: Europe Transdermal Medical Patch Market Breakdown, by Distribution Channel
- 10.2.1.6 Rest of Europe:
Europe Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.6.1 Rest of Europe: Europe Transdermal Medical Patch Market Breakdown, by Type
- 10.2.1.6.2 Rest of Europe: Europe Transdermal Medical Patch Market Breakdown, by Application
- 10.2.1.6.3 Rest of Europe: Europe Transdermal Medical Patch Market Breakdown, by Distribution Channel
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Hisamitsu Pharmaceutical Co Inc
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Medline Industries LP
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Johnsons and Johnsons
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Novartis AG
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Teva Pharmaceutical Industries Ltd.
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 UCB SA
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Viatris Inc
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Endo International Inc
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Boehringer Ingelheim International GmbH
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations
Get Free Sample For Europe Transdermal Medical Patch Market
